Preparation of radioiodinated ritodrine as a potential agent for lung imaging

Journal of Radioanalytical and Nuclear Chemistry - Tập 300 - Trang 1227-1233 - 2014
H. M. Rashed1, I. T. Ibrahim1, M. A. Motaleb1, A. Abd El-Bary2
1Labeled Compound Department, Hot Laboratory Center, Atomic Energy Authority, Cairo, Egypt
2Pharmaceutics Department, Faculty of Pharmacy, Cairo University, Giza, Egypt

Tóm tắt

Ritodrine (a beta-2 adrenergic receptor agonist) was successfully labeled with 125I via direct electrophilic substitution reaction at ambient temperature. 125I-ritodrine was obtained with a maximum labeling yield of 97 ± 0.163 % and in vitro stability up to 24 h. Biodistribution studies showed that maximum in vivo uptake of 125I-ritodrine in lungs was 20.4 ± 0.22 % injected activity/g tissue at 1 h post-injection, whereas the clearance from mice appeared to proceed mainly via the renal pathway. 125I-ritodrine is not a blood product and so it is more safe than the currently available 99mTc-MAA, and its lung uptake is higher than that of the recently discovered 99mTc(CO)5I and 99mTc-DHPM. As a conclusion, radioiodinated ritodrine could be used as a novel radiopharmaceutical for lung perfusion scan safer than the currently available 99mTc-MAA and more potential than the recently discovered 99mTc(CO)5I and 99mTc-DHPM.

Tài liệu tham khảo

Anger K (1990) Radiologic diagnosis of chest disease. pp 141–153 Pettersson H, Schulthess GK, Allison DJ, Carty H, Resnick D, Baert AL, Smith HJ, Boutin RD, Andersson I, Grenier P, Ringertz H, Coakley F, Hricak H, Higgins CB, Hermans R, Scotti G (1998) The encyclopaedia of medical imaging Raoof S, Raoof S, Naidich DP (2004) Curr Opin Pulm Med 10(5):383–389 Miniati M, Pistolesi M, Marini C, Ricco GD, Formichi B, Prediletto R, Allescia G, Tonelli L, Sostman HD, Giuntini C (1996) Am J Respir Crit Care Med 154:1387–1393 Christian JA, Partridge M, Nioutsikou E, Cook G, McNair HA, Cronin B, Courbon F, Bedford JL, Brada M (2005) Radiother Oncol 77(3):271–277 Tommaso B, Oboldi D, Pier LG, Francesca RM, Paola R, Gabriella N, Giampaolo G (2008) Invest Radiol 43:368–373 Klaus Z, Claudia BS, Jörg P, Joachim K (2009) Ann Nucl Med 23:1–16 Vijayvergiya R, Mittal BR, Grover A, Hariram V, Bhattacharya A, Singh B (2009) Int J Cardiol 133:122–125 Miroslavov AE, Gorshkov NI, Lumpov AL, Yalfimov AN, Suglobov DN, Ellis BL, Braddock R, Smith AM, Prescott MC, Lawson RS, Sharma HL (2009) Nucl Med Biol 36:73–79 De K, Chandra S, Sarkar B, Ganguly S, Misra M (2010) J Radioanal Nucl Chem 283:621–628 Mutlu GM, Factor P (2008) Am J Respir Cell Mol Biol 38(2):127–134 Witter FR, Zimmerman AW, Reichmann JP, Connors SL (2009) Am J Obstet Gynecol 201(6):553–559 Rabai G, Beck MT, Kustin K, Epstein IR (1989) J Phys Chem 93(7):2853–2858 El-Sherbiny DT, El-Ghaffar MA, El-Wasseef DR, El-Ashry SM (2010) J Liq Chromatogr Relat Technol 33:1476–1486 Motaleb MA, El-Kolaly MT, Rashed HM, El-Bary AA (2011) J Radioanal Nucl Chem 289:915–921 Rhodes BA (1974) Sem Nucl Med 4:281–293 Adam MJ, Wilbur DS (2005) Chem Soc Rev 34:153–163 El-Ghany EA, El-Mohty AA, Zaghary WA, El-Kolaly MT, Raich M, El-Bary AA (1998) J Radioanal Nucl Chem 232:223–228 El-Ghany EA, Amine AM, EL-Sayed AS, EL-Kolaly MT, El-Gelil FA (2005) J Radioanal Nucl Chem 266:117–124 Sakr TM, Motaleb MA, Ibrahim IT (2012) J Radioanal Nucl Chem 292:705–710 El-Azony KM (2010) J Radioanal Nucl Chem 285:315–320 Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sjöberg S (2002) Radiochem Acta 90:229–235 Puttaswamy, Sukhdev A, Shubha JP (2009) J Mol Cat A Chem 310:24–33 Amin AM, El-Bary AA, El-Mohty AA, Saad SM, El-Sharawy DM (2013) Nat Sci 5:526–531